BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16530782)

  • 21. Comparative analysis of human cytomegalovirus-specific CD4(+) T-cell frequency and lymphoproliferative response in human immunodeficiency virus-positive patients.
    Piccinini G; Comolli G; Genini E; Lilleri D; Gulminetti R; Maccario R; Revello MG; Gerna G
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1225-30. PubMed ID: 11687467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of high-dose chemotherapy on antigen-specific T cell immunity in breast cancer patients. Application of new flow cytometric method.
    Svane IM; Nikolajsen K; Hansen SW; Kamby C; Nielsen DL; Johnsen HE
    Bone Marrow Transplant; 2002 Apr; 29(8):659-66. PubMed ID: 12180110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation.
    Lilleri D; Gerna G; Fornara C; Chiesa A; Comolli G; Zecca M; Locatelli F
    J Infect Dis; 2009 Mar; 199(6):829-36. PubMed ID: 19239337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation.
    Ganepola S; Gentilini C; Hilbers U; Lange T; Rieger K; Hofmann J; Maier M; Liebert UG; Niederwieser D; Engelmann E; Heilbronn R; Thiel E; Uharek L
    Bone Marrow Transplant; 2007 Mar; 39(5):293-9. PubMed ID: 17262060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
    Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
    J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Major contribution of codominant CD8 and CD4 T cell epitopes to the human cytomegalovirus-specific T cell repertoire.
    Nastke MD; Herrgen L; Walter S; Wernet D; Rammensee HG; Stevanović S
    Cell Mol Life Sci; 2005 Jan; 62(1):77-86. PubMed ID: 15619009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of an elispot assay to detect cytomegalovirus-specific CD8+ T lymphocytes.
    Godard B; Gazagne A; Gey A; Baptiste M; Vingert B; Pegaz-Fiornet B; Strompf L; Fridman WH; Glotz D; Tartour E
    Hum Immunol; 2004 Nov; 65(11):1307-18. PubMed ID: 15556681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
    La Rosa C; Wang Z; Lacey SF; Lalimarmo MM; Krishnan A; Longmate J; Diamond DJ
    Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid reconstitution of CMV-specific T-cells after stem-cell transplantation.
    Widmann T; Sester U; Schmidt T; Gärtner BC; Schubert J; Pfreundschuh M; Sester M
    Eur J Haematol; 2018 Jul; 101(1):38-47. PubMed ID: 29652096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detailed analysis of IFNg response upon activation permits efficient isolation of cytomegalovirus-specific CD8+ T cells for adoptive immunotherapy.
    Zandvliet ML; Falkenburg JH; Jedema I; Willemze R; Guchelaar HJ; Meij P
    J Immunother; 2009 Jun; 32(5):513-23. PubMed ID: 19609244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation.
    Cummins NW; Deziel PJ; Abraham RS; Razonable RR
    Transpl Infect Dis; 2009 Feb; 11(1):20-7. PubMed ID: 18811629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers.
    Revello MG; Lilleri D; Zavattoni M; Furione M; Genini E; Comolli G; Gerna G
    J Infect Dis; 2006 Jan; 193(2):269-76. PubMed ID: 16362891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
    Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
    J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High level of perforin expression in T cells: An early prognostic marker of the severity of herpesvirus reactivation after allogeneic stem cell transplantation in adults.
    Pietersma FL; van Dorp S; Jacobi R; Ran L; Nanlohy NM; Schuurman R; Minnema MC; Meijer E; van Baarle D
    Clin Infect Dis; 2010 Mar; 50(5):717-25. PubMed ID: 20121571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of CD95 and CD38 expression in peripheral blood T lymphocytes during active human cytomegalovirus infection after orthotopic liver transplantation.
    Wang Y; Liu Y; Han R; Li Q; Yao Z; Niu W; Yuan Y; Tang Z; Zhu Z; Shen Z
    J Gastroenterol Hepatol; 2010 Jan; 25(1):138-42. PubMed ID: 19817952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of human cytomegalovirus infection in patients infected with human immunodeficiency virus by high levels of specific CD8+ T-cells.
    Lilleri D; Chiesa A; Fornara C; Maserati R; Lozza L; Comolli G; Gerna G
    Clin Microbiol Infect; 2007 Jan; 13(1):19-24. PubMed ID: 17184283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT.
    Król L; Stuchlý J; Hubáček P; Keslová P; Sedláček P; Starý J; Hrušák O; Kalina T
    Bone Marrow Transplant; 2011 Aug; 46(8):1089-98. PubMed ID: 21057553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV.
    Walker S; Fazou C; Crough T; Holdsworth R; Kiely P; Veale M; Bell S; Gailbraith A; McNeil K; Jones S; Khanna R
    Transpl Infect Dis; 2007 Jun; 9(2):165-70. PubMed ID: 17462006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor.
    Grigoleit GU; Kapp M; Hebart H; Fick K; Beck R; Jahn G; Einsele H
    J Infect Dis; 2007 Sep; 196(5):699-704. PubMed ID: 17674311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry.
    Maecker HT; Maino VC
    Hum Immunol; 2004 May; 65(5):493-9. PubMed ID: 15172449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.